Biofilm disruption potential of a glycolipid biosurfactant from marine Brevibacterium casei

113Citations
Citations of this article
145Readers
Mendeley users who have this article in their library.

Abstract

The antibiofilm activity of a glycolipid biosurfactant isolated from the marine actinobacterium Brevibacterium casei MSA19 was evaluated against pathogenic biofilms in vitro. The isolate B. casei MSA19 was a potential biosurfactant producer among the 57 stable strains isolated from the marine sponge Dendrilla nigra. The biosurfactant production was optimized under submerged fermentation. The purified glycolipid showed a broad spectrum of antimicrobial activity. Based on the minimum inhibitory concentration/minimum bactericidal concentration ratio, the glycolipid was determined as bacteriostatic. The glycolipid biosurfactant disrupted the biofilm formation under dynamic conditions. The disruption of the biofilm by the MSA19 glycolipid was consistent against mixed pathogenic biofilm bacteria. Therefore, the glycolipid biosurfactant can be used as a lead compound for the development of novel antibiofilm agents. © 2010 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Kiran, G. S., Sabarathnam, B., & Selvin, J. (2010). Biofilm disruption potential of a glycolipid biosurfactant from marine Brevibacterium casei. FEMS Immunology and Medical Microbiology, 59(3), 432–438. https://doi.org/10.1111/j.1574-695X.2010.00698.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free